Cargando…
Mutant p53: it’s not all one and the same
Mutation of the TP53 tumor suppressor gene is the most common genetic alteration in cancer, and almost 1000 alleles have been identified in human tumors. While virtually all TP53 mutations are thought to compromise wild type p53 activity, the prevalence and recurrence of missense TP53 alleles has mo...
Autores principales: | Kennedy, Margaret C., Lowe, Scott W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090915/ https://www.ncbi.nlm.nih.gov/pubmed/35361963 http://dx.doi.org/10.1038/s41418-022-00989-y |
Ejemplares similares
-
Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019) -
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
por: Muller, Patricia A.J., et al.
Publicado: (2014) -
Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020) -
Cancer Cachexia and Dysregulated Phosphate Metabolism: Insights from Mutant p53 and Mutant Klotho Mouse Models
por: Brown, Ronald B.
Publicado: (2022) -
Mutant p53—a potential player in shaping the tumor–stroma crosstalk
por: Stein, Yan, et al.
Publicado: (2019)